Astrocytes play a crucial role in the formation and evolution of MS lesions – Commentary

Burda JE Sofroniew MV. Reactive gliosis and the multicellular response to CNS damage and disease. Neuron 2014; 81: 229–248.

Wheeler MA Quintana FJ. Regulation of astrocyte functions in multiple sclerosis. Cold Spring Harb perspect Med. Epub ahead of print 22 January 2018. DOI: 10.1101/cshperspect.a029009.

Kerlero de Rosbo N . Astrocytes play a crucial role in the formation and evolution of MS lesions - No. Mult Scler 2019; 25: 17–19.

Pitt D Ponath G . Astrocytes play a crucial role in the formation and evolution of MS lesions � Yes. Mult Scler 2019; 25: 15–17.

Alvarez JI Dodelet-Devillers A Kebir H et al . The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. Science 2011; 334: 1727–1731.

Horng S Therattil A Moyon S et al . Astrocytic tight junctions control inflammatory CNS lesion pathogenesis. J Clin Invest 2017; 127: 3136–3151.

Quintana FJ. Astrocytes to the rescue! Glia limitans astrocytic endfeet control CNS inflammation. J Clin Invest 2017; 127: 2897–2899.

Chihara N Madi A Kondo T et al . Induction and transcriptional regulation of the co-inhibitory gene module in T cells. Nature 2018; 558: 454–459.

Mascanfroni ID Takenaka MC Yeste A et al . Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha. Nat Med 2015; 21: 638–646.

Mascanfroni ID Yeste A Vieira SM et al . IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat Immunol 2013; 14: 1054–1063.

Mayo L Trauger SA Blain M et al . Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat Med 2014; 20: 1147–1156.

Rothhammer V Mascanfroni ID Bunse L et al . Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat Med 2016; 22: 586–597.

Rothhammer V Quintana FJ. Control of autoimmune CNS inflammation by astrocytes. Semin Immunopathol 2015; 37: 625–638.

Liddelow SA Guttenplan KA Clarke LE et al . Neurotoxic reactive astrocytes are induced by activated microglia. Nature 2017; 541: 481–487.

Rothhammer V Borucki DM Tjon EC et al . Microglial control of astrocytes in response to microbial metabolites. Nature 2018; 557: 724–728.

Rothhammer V Kenison JE Tjon E et al . Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation. Proc Natl Acad Sci U S A 2017; 114: 2012–2017.

Baecher-Allan C Kaskow BJ Weiner HL. Multiple sclerosis: Mechanisms and immunotherapy. Neuron 2018; 97: 742–768.

Thompson AJ. Challenge of progressive multiple sclerosis therapy. Curr Opin Neurol 2017; 30: 237–240.

Thompson AJ Baranzini SE Geurts J et al . Multiple sclerosis. Lancet 2018; 391: 1622–1636.